Measurement of multiple drug resistance transporter activity in putative cancer stem/progenitor cells.
about
Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease ProgressionEmerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachCharacterization of rhodamine-123 as a tracer dye for use in in vitro drug transport assaysKIT (CD117) expression in a subset of non-small cell lung carcinoma (NSCLC) patientsEcto-5'-nucleotidase (CD73) is a biomarker for clear cell renal carcinoma stem-like cells.Single-cell tracking with a reversing flow cytometer.In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.Localization of CD44 and CD90 positive cells to the invasive front of breast tumors.Kinetic analysis of intracellular Hoechst 33342--DNA interactions by flow cytometry: misinterpretation of side population status?Homeobox gene Rhox5 is regulated by epigenetic mechanisms in cancer and stem cells and promotes cancer growth.What Tumor Dynamics Modeling Can Teach us About Exploiting the Stem-Cell View for Better Cancer Treatment.MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis.Ovarian cancer stem cells: elusive targets for chemotherapy.Cancer stem cells, tumor dormancy, and metastasis.Investigating molecular profiles of ovarian cancer: an update on cancer stem cells.Human pancreatic cancer progression: an anarchy among CCN-siblings.The Mesenchymal State Predicts Poor Disease-Free Survival in Resectable Non-Small Cell Lung Cancer.VSV based virotherapy in ovarian cancer: the past, the present and …future?Flow cytometric determination of stem/progenitor content in epithelial tissues: an example from nonsmall lung cancer and normal lung.Characterization of disease progression in ovarian cancer by utilizing 'chemograms' of ovarian cancer stem cells.Heterogeneity of Stem Cells: A Brief Overview.
P2860
Q26829949-67525ECD-7FB7-4F9A-B002-FA916783D798Q26849477-F8594D4C-3471-41F4-BF22-664B80E4BDDBQ28481706-7E2BEB48-AB4E-42A0-AE21-431911521237Q28484518-FB23E463-41EA-4EA9-98F8-5E64468AB722Q33761985-3B4ECF9D-BC8C-41DA-9778-EFA743136A16Q33779335-13D397A9-18C4-45DF-981F-8F58540FA10DQ33816271-632ADB77-0FED-4393-89EE-D974957E7D60Q34186515-0E8C5D12-B098-4FEF-8B33-1444E79F7722Q34470778-B1DA54B0-6C53-43BC-BDB2-2F68C74A0EB5Q35074440-DD62AB78-77A2-4AD4-8E9D-3374D89C9A27Q35135634-8FF9A435-DC96-4D23-9171-F9B3A4D2DE9BQ36381924-37FBF5A8-7135-4723-A981-A5A38B4FC15DQ38013671-17E4B720-AB87-4051-AEB5-F0B13172EB21Q38056500-CAE6B974-D6C2-4135-98A0-543B6C923957Q38203882-D5C07681-14FA-490A-9E2A-D68C0EAF8EC1Q38931858-EB493868-5BBF-4630-8682-A13C63192AF8Q40203362-CA791F1F-4F56-41E5-A77D-467901ADCB3EQ41441101-5880713C-8C9A-4F3D-AEFA-72660A9FC28FQ42875098-39F16199-7076-4F58-8501-1B7392A10A3FQ45077649-6972B532-1F31-4F56-87FD-DE54B1091AF4Q52876941-7038ECA9-3743-49F0-AB47-D11190C20F8E
P2860
Measurement of multiple drug resistance transporter activity in putative cancer stem/progenitor cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Measurement of multiple drug r ...... cancer stem/progenitor cells.
@ast
Measurement of multiple drug r ...... cancer stem/progenitor cells.
@en
type
label
Measurement of multiple drug r ...... cancer stem/progenitor cells.
@ast
Measurement of multiple drug r ...... cancer stem/progenitor cells.
@en
prefLabel
Measurement of multiple drug r ...... cancer stem/progenitor cells.
@ast
Measurement of multiple drug r ...... cancer stem/progenitor cells.
@en
P2093
P2860
P1476
Measurement of multiple drug r ...... cancer stem/progenitor cells.
@en
P2093
Albert D Donnenberg
E Michael Meyer
Vera S Donnenberg
P2860
P304
P356
10.1007/978-1-59745-280-9_17
P407
P577
2009-01-01T00:00:00Z